Individuals with a more severe MFS phenotype may have a second variant (pathogenic or of uncertain significance) in another MFS/thoracic aortic aneurysm/cerebral aneurysm gene, for example, COL4A1, as demonstrated in nine of 51 severely affected cases (Aubart et al., 2018). The gene discussed is COL4A1; the disease is Marfan syndrome.